Oncolo-Co
The computed 12-month bankruptcy probability of Oncolo-Co is 0.4% (very low). The 2024 annual accounts show negative equity (€-4k) and a net result of €1k. Equity is shrinking by ~198.6% per year across the filed fiscal years. Its solvency ranks better than 5% of 1234 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-4k |
| Net result | €1k |
| Better than sector | 5% |
| Active | 4 yrs |
Fragile profile — watch profitability in particular.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -0.3% | 68.2% | |
| Net result | €1k | €40k | |
| Equity | €-4k | €79k | |
| Gross operating margin | €172k | €69k | |
| Total assets | €1.55M | €147k |
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €170k |
| Net profit | €1k |
| Cash flow | €119k |
| Staff costs | — |
| Income taxes | €3k |
| Dividends | — |
| Total assets | €1.55M |
| Equity | €-4k |
| Debt | €1.05M |
| of which ≤ 1y | €66k |
| of which > 1y | €986k |
| Working capital | €-31k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 0.54 |
| Quick ratio | 0.54 |
| Working capital ratio | -2.0% |
| Solvency | -0.3% |
| Debt / equity | -239.34 |
| Long-term debt ratio | -224.35 |
| Interest coverage | 3.60 |
| Gross margin | — |
| Net margin | — |
| ROA | 0.1% |
| ROE | -25.9% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €1.55M |
| Fixed assets | 21/28 | €1.52M |
| Intangible fixed assets | 21 | €98k |
| Tangible fixed assets | 22/27 | €1.42M |
| Current assets | 29/58 | €35k |
| Amounts receivable within one year | 40/41 | €3k |
| Cash & bank | 54/58 | €31k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.55M |
| Equity | 10/15 | €-4k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €-7k |
| Provisions & deferred taxes | 16 | €507k |
| Amounts payable | 17/49 | €1.05M |
| Amounts payable after one year | 17 | €986k |
| Amounts payable within one year | 42/48 | €66k |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €172k |
| Operating result | 9901 | €52k |
| Financial income | 75 | €67 |
| Financial charges | 65 | €47k |
| Result before taxes | 9903 | €5k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €1k |
| Result to be appropriated | 9905 | €1k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 12-01-2022 |
| Status | Active |
| Postal code | 1190 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11803C1078/00F000 | Flanders | 704 m² | 1 · 591 m² | 34.1 m · 10 fl. |
| 21383B0011/00N005 | Brussels | 399 m² | 1 · 145 m² | 18.9 m · 5 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
18-02-2026 Registered office moved from Antwerpen to Vorst
- Lange Gasthuisstraat 13 bus 202 2000 Antwerpen → 1190 Vorst (Brussel), Besmelaan 103
Technical details
{
"events": [
{
"kind": "zetel_transfer_cross_border_in",
"seat_type": "siege_social",
"new_address": {
"raw": "1190 Vorst (Brussel), Besmelaan 103",
"city": "Vorst",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Besmelaan",
"country": "BE",
"postcode": "1190",
"box_number": null,
"street_number": "103",
"locality_suffix": "(Brussel)"
},
"old_address": {
"raw": "Lange Gasthuisstraat 13 bus 202\n2000 Antwerpen",
"city": "Antwerpen",
"region": "vlaams_gewest",
"street": "Lange Gasthuisstraat",
"country": "BE",
"postcode": "2000",
"box_number": "202",
"street_number": "13",
"locality_suffix": null
},
"effective_date": null,
"evidence_quote": "",
"region_changed": true,
"is_statute_change": true,
"nationality_change": true,
"old_address_source": "header_volledig_adres",
"statute_clause_text": "Artikel 2: Zetel.\nDe zetel is gevestigd in het Brussels hoofdstedelijk gewest.\nDe zetel kan worden overgebracht naar om het even welke plaats in het Nederlands taalgebied of het\ntweetalig gebied Brussel Hoofdstad door eenvoudige beslissing van het bestuursorgaan, die alle\nimachten heeft teneinde op authentieke wijze de eventuele statutenwijziging die eruit voortvloeit, te\ndoen vaststellen, zonder dat dit aanleiding mag geven tot een wijziging van de taal van de statuten.\nDe vennootschap kan, bij",
"statute_article_number": 2,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Philippe COLSON",
"firm_city": null,
"firm_name": "Benijts \u0026 Colson",
"office_city": "Geel",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-02-18",
"filing_date": "2026-02-10",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2026-01-22",
"unanimous": null
},
"subject_company": {
"kbo": "0780.358.961",
"name_full": "ONCOLO-CO",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0799.877.143",
"org_name": "DKF Fiduciaire",
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expeditie van de akte",
"geco\u00F6rdineerde statuten"
]
}18-02-2026 Registered office moved from Antwerpen to Vorst (Brussel)
- Lange Gasthuisstraat 13, 2000 Antwerpen → Besmelaan 103, 1190 Vorst (Brussel)
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Vorst (Brussel)",
"region": "Brussels",
"street": "Besmelaan",
"country": "BE",
"postcode": "1190",
"box_number": null,
"street_number": "103"
},
"old_address": {
"city": "Antwerpen",
"region": null,
"street": "Lange Gasthuisstraat",
"country": "BE",
"postcode": "2000",
"box_number": "202",
"street_number": "13"
},
"effective_date": "2026-01-22",
"evidence_quote": "De vergadering besluit om de zetel van de vennootschap te verplaatsen naar het Brussels hoofdstedelijk gewest, met name te 1190 Vorst (Brussel), Besmelaan 103; en dit met ingang vanaf Iheden."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0780.358.961",
"name_full": "ONCOLO-CO",
"legal_form": "BV"
}
}18-09-2025 Capital increase of €10,000 to €10,000
- €0 → €10.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10000.0,
"delta_eur": 10000.0,
"before_eur": 0.0,
"share_emission": {
"agio_eur": 0.0,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 400,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 25.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 10000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Philippe COLSON",
"firm_city": null,
"firm_name": "Benijts \u0026 Colson",
"office_city": "Geel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-09-18",
"filing_date": "2025-09-16",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-09-11",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-09-11"
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0780.358.961",
"name_full": "Oncolo-Co",
"legal_form": "B.V.",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [],
"share_classes_after": []
}18-09-2025 Capital increase of €10,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 10000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 10000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-09-11",
"evidence_quote": "De vergadering besluit om het vermogen van de vennootschap \u2013 bij wijze van inbreng in geld - te verhogen met een totaal bedrag tienduizend euro (\u20AC 10.000,00).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0780.358.961",
"name_full": "ONCOLO-CO",
"legal_form": "BV"
}
}14-01-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "2000 Antwerpen, Lange Gasthuisstraat 13 bus 202",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "GELDHOF Vincent Jorg",
"niss": null,
"address": "3000 Leuven, Vaartkom 11 /0303"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "GELDHOF Vincent Jorg",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "0780.358.961",
"name_full": "Oncolo-Co",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-01-11",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Oncolo-Co |